Among the baseline characteristics, age, tumor stage, tumor site, MSI-H phenotype, BRAF mutation, and PIK3CA mutation were significantly different across the four clusters (Table 1) and were adjusted in the following survival analysis. The gene discussed is PIK3CA; the disease is neoplasm.